Description: Biomedical Batteries / Liko Inc / Likorall R2R Patient Lift
- Applications: Medical Equipment
- Battery Type: Lead Acid Batteries
Supplier: Bourns, Inc.
Description: RES NET,THICK FILM,10K OHMS,100WV,2% +/-TOL,-100,100PPM TC
- Configuration: Resistor Chip Array
- Category / Application: General Use
Supplier: Perfect Parts Corporation
Description: RES NET,THICK FILM,1.2K OHMS,100WV,2% +/-TOL,-100,100PPM TC
- Configuration: Resistor Network
Supplier: Medical Isotopes, Inc.
Description: (1’R,2R)-2-[(1’,2’-O-Isopropylidene)dihydroxyethyl] -6-fluorochroman-4-one
Supplier: Digi-Key Corporation
Description: RES NET MULT OHM 15 RES 16DIP
- Configuration: Resistor Network
- Mounting / Packaging: Through Hole, Other
- Packing Method: Shipping Tube / Stick Magazine
- Standard and Compliances: RoHS Compliant
Supplier: Techwell, Inc.
Description: Key Features CMOS Low Power (Typ) 100mW R2R Output, Segmented for Low "Glitch" CMOS/TTL Compatible Inputs Fast Settling (Typ) 20ns to 1/2 LSB Feedthrough Latch for Clocked or Unclocked Use Accuracy (Typ) ±0.5 LSB Data Complement Control High Update Rate (Typ) 50MHz Unipolar
- Reference Access: External
Supplier: American Microsemiconductor, Inc.
Description: 2 ref.inputs;R-2R DAC
- IC Package Type: Other
Find Suppliers by Category Top
Parts by Number for R2R Top
|Part #||Distributor||Manufacturer||Product Category||Description|
|LMV331IDCKR/R2R||ASAP Semiconductor||NSC||Not Provided||Not Provided|
|4116R-R2R-253||ASAP Semiconductor||BOURNS||Not Provided||THICK FILM MOLDED DIP|
|4308R-R2R-503L||ASAP Semiconductor||BOURNS||Not Provided||Fixed Re|
|4610X-R2R-122LF||ASAP Semiconductor||BOURNS||Not Provided||Not Provided|
|10X-R2R-253||ASAP Semiconductor||BROWN 9813||Not Provided||Not Provided|
Conduct Research Top
D/A Conversion Using PWM and R-2R Ladders to Generate Sine and DTMF Waveforms
of complex analog waveforms.: (PWM and R-2R Ladder). Both the Pulse Width Modulation (PWM) and resistor ladders require only a few external components to create a D/A converter with the PICmicro? microcontroller series. These techniques can be used to generate dual-tone multiplexed frequencies (DTMF
Medical Device Link .
The Center for Advanced Microelectronics Manufacturing (CAMM; Endicott, NY; ) is driving research and development to produce microelectronic components in a roll-to-roll (R2R) format. CAMM is a collaborative effort by Binghamton University (Binghamton, NY; ), Endicott Interconnect Technologies Inc
MICRO: Improving Overlay Performance
that balancing act requires the use of process control strategies, including run-to-run (R2R) control. R2R control is achieved by gathering metrology and process tool data from previously processed production lots, analyzing the accumulated raw data, and forecasting optimum command offsets
MICRO: Round the Bitchin' Circuit
in 1999, will share with USDC the nearly $2 million cost of a multiphase project to scale up high-volume, roll-to-roll (R2R) manufacturing capability for the production of flexible OLEDs.
The Camara Oscura Being Developed by South Coast Photonics Could Revolutionize the Way Roll-to-Roll Manufacturing of Electronic
(flexible organic light-emitting device) features, the potential may even be much greater, says a market report from One of the most common methods used to make thin-film electronics is roll-to-roll (r2r) manufacturing, and there are currently
MICRO: Taking Control
data. Based on production fab trial test and beta test data, the article illustrates how fabs can achieve both accurate and automatic control by accounting for maintenance events in their overall control strategy. Two major types of run-to-run (R2R) control methodologies are available: proportional
MICRO:Taking Control 2
to uncontrolled drift in polishing process results. Virtually all CMP processes, therefore, update polishing tool recipes either automatically or manually to compensate for such disturbances. The most effective means of compensating for disturbances is automated run-to-run (R2R) control, batch
Inadequate Instrument Qualification and Analytical
In 2011, almost three times as many US FDA. warning letters and FDA Form 483s were issued to. pharmaceutical and biopharmaceutical manufacturers. compared to 2010. The companies receiving these. citations in China, India, Canada, Spain, the United. Kingdom, and the United States were cited for